PubRank

Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic

Clinical Trial ID NCT01643278

PubWeight™ 15.79‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01643278

Top papers

Rank Title Journal Year PubWeight™‹?›
1 At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol 2013 1.90
2 Cancer immunotherapy in clinical practice -- the past, present, and future. Chin J Cancer 2014 0.98
3 The biology of uterine sarcomas: A review and update. Mol Clin Oncol 2013 0.92
4 Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander". Toxins (Basel) 2014 0.92
5 Prospects and pitfalls of personalizing therapies for sarcomas: from children, adolescents, and young adults to the elderly. Curr Oncol Rep 2014 0.89
6 Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy. Paediatr Drugs 2015 0.86
7 The past, present and future of immunotherapy against tumor. Transl Lung Cancer Res 2015 0.85
8 The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets. Biosci Rep 2014 0.83
9 Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions. Drugs 2015 0.83
10 Sarcoma immunotherapy: past approaches and future directions. Sarcoma 2014 0.81
11 Targeted therapies for advanced Ewing sarcoma family of tumors. Cancer Treat Rev 2015 0.81
12 Immunological off-target effects of imatinib. Nat Rev Clin Oncol 2016 0.81
13 Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013. Clin Sarcoma Res 2014 0.80
14 The GIST of targeted therapy for malignant melanoma. Ann Surg Oncol 2014 0.80
15 Current Immunotherapies for Sarcoma: Clinical Trials and Rationale. Sarcoma 2016 0.79
16 Targeted therapy in cancer. Cancer Chemother Pharmacol 2015 0.75
17 The Role of Adaptive Immunity in the Efficacy of Targeted Cancer Therapies. Trends Immunol 2016 0.75
18 Evaluating the Role of Interdigitated Neoadjuvant Chemotherapy and Radiation in the Management of High-Grade Soft-Tissue Sarcoma: The Johns Hopkins Experience. Am J Clin Oncol 2014 0.75
Next 100